A risk assessment of the ward-based preparation of parenteral medicines

Hospital Pharmacist

Volumn 10, Issue 7, 2003, Pages 306-308

  Beaney, A M ^a   Goode, J ^a  

^a FREEMAN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIVIRUS AGENT; GANCICLOVIR;

ANTIBIOTIC THERAPY; ARTICLE; CLINICAL PHARMACY; ENVIRONMENTAL MONITORING; HOSPITAL PERSONNEL; HUMAN; INFECTION; NURSE; PATIENT CARE; PHARMACIST; PHARMACY; PRACTICE GUIDELINE; QUESTIONNAIRE; RISK ASSESSMENT; TRAINING;

EID: 0042125254     PISSN: 13527967     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. HC(76)9; 1976 (The Breckenridge report)
2. NHS North West, Maintaining asepsis during the preparation of pharmaceutical products. November 1997
3. Executive Letter EL (96) 95. UK Department of Health
4. Executive Letter EL (97) 52. UK Department of Health
5. Editor Beaney AM. Quality assurance of aseptic preparation Services. Third Edition Pharmaceutical Press London 2001.
6. Rules and Guidance for Pharmaceutical Manufacturers and Distributors HMSO 1997
7. Note for guidance on the maximum shelf life for sterile products for human use after first opening. Committee for Proprietary Medicinal Products EMEA 1998.
8. Anon. Trust fined for malaria death. Pharmaceutical Journal, Vol 264, 281.
9. Bennett SN., McNeill MM, Bland LA, Arduino MJ, Villarino ME, DM et al. Post-operative infections traced to contamination of intravenous anaesthetic, propofol. New England Journal of Medicine 1995;333:146-154